Literature DB >> 30004018

The advances in CRISPR technology and 3D genome.

William Wang1, Linlin Zhang2, Xiangdong Wang3, Yiming Zeng4.   

Abstract

The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) system is a prokaryotic immune system that used to resist foreign genetic factors. It rapidly becomes the hot technology in life sciences and is applies for genome editing to solve the problem of genome-derived diseases. Using CRISPR/Cas technique, the biological DNA sequence can be repaired, cut, replaced, or added. It can effectively change the human stem cells and is expected to achieve results in the treatment. Compared with ZFN and TALEN genome editing techniques, CRISPR is more effective, accurate, and convenient. The application of CRISPR technique in three dimensional (3D) genome structure makes us understand the relationship between linear DNA sequence and 3D chromatin structure. Utilizing CRISPR/Cas9 genome editing to reverse or delete CTCF binding sites, to recognize changes of topological isomerism of the genome and interactions between chromatin loops. The purpose of this review is to introduce the characteristics and classification of the current CRISPR/Cas system, multiple functions, and potential therapeutic uses, as well as to outline the effect of the technique on chromatin loops by changing CTCF sites in 3D genomes. We will also briefly describe the importance of ethical dilemmas to be faced in CRISPR applications and provide a perspective for potential CRISPR considerations.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  CRISPR; CTCF; Cas; DNA; Genome

Mesh:

Substances:

Year:  2018        PMID: 30004018     DOI: 10.1016/j.semcdb.2018.07.009

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  4 in total

Review 1.  Engineering 3D genome organization.

Authors:  Haifeng Wang; Mengting Han; Lei S Qi
Journal:  Nat Rev Genet       Date:  2021-02-08       Impact factor: 53.242

Review 2.  CRISPR-Cas technology a new era in genomic engineering.

Authors:  Ali Parsaeimehr; Rosemary I Ebirim; Gulnihal Ozbay
Journal:  Biotechnol Rep (Amst)       Date:  2022-04-12

Review 3.  A review of COVID-19: Treatment strategies and CRISPR/Cas9 gene editing technology approaches to the coronavirus disease.

Authors:  Muhammad Farhat Ullah; Yasir Ali; Muhammad Ramzan Khan; Inam Ullah Khan; Bing Yan; M Ijaz Khan; M Y Malik
Journal:  Saudi J Biol Sci       Date:  2021-10-13       Impact factor: 4.219

4.  The application of CRISPR/Cas9 system in cervical carcinogenesis.

Authors:  Chun Gao; Ping Wu; Lan Yu; Liting Liu; Hong Liu; Xiangyu Tan; Liming Wang; Xiaoyuan Huang; Hui Wang
Journal:  Cancer Gene Ther       Date:  2021-08-04       Impact factor: 5.854

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.